Expression of TREM-1 mRNA in acute pancreatitis - PubMed (original) (raw)
Expression of TREM-1 mRNA in acute pancreatitis
Da-Yu Wang et al. World J Gastroenterol. 2004.
Abstract
Aim: To explore the expression of triggering receptor expressed on myeloid cells (TREM-1) mRNA in acute pancreatitis (AP).
Methods: Using the reverse transcription polymerase chain reaction (RT-PCR), we examined the expression of TREM-1 mRNA in 10 cases of mild acute pancreatitis (MAP), 8 cases of severe acute pancreatitis (SAP), and 10 cases of healthy control subjects. And we also examined the expression of TREM-1 mRNA in 14 cases of AP (including 10 MAP and 4 SAP) before treatment, after successful therapy and clinically cured.
Results: The expression of TREM-1 mRNA in the groups of MAP, SAP patients and healthy control subjects was 0.771+/-0.274, 1.092+/-0.331 and 0.459+/-0.175, respectively; there was a significant difference among the three groups (P<0.05). And there was also a significant difference between the AP patients (0.914+/-0.341) and healthy control subjects (0.459+/-0.175) (P<0.05). Moreover, in the 14 cases of AP, before treatment, after successful therapy and clinically cured, the expression of TREM-1 mRNA was 0.905+/-0.226, 0.739+/-0.169 and 0.633+/-0.140, respectively, and there was a significant difference among the three stages (P<0.05).
Conclusion: The expression of TREM-1 mRNA in the patients with AP increases obviously, and correlates with the degree of AP. Furthermore, the expression of TREM-1 mRNA is distinctly different at the different stages of AP. It indicates TREM-1 may play an important role in the occurrence and development of AP.
Figures
Figure 1
Electrophoresis of the PCR products. M: DL2000 marker; 1: the PCR product of normal subject; 2: the PCR product of MAP; 3: the PCR product of SAP. The amplified fragment lengths of β-actin and TREM-1 are 520 bp and 232 bp respectively.
Figure 2
The A ratios of TREM-1/β-actin in different degree of AP: There was a significant difference among the three groups in the expressions of TREM-1 mRNA (P < 0.05). And between the AP patients and healthy control subjects, the difference was significant (P < 0.05).
Figure 3
Electrophoresis of the PCR products. M: DL2000 marker; 1: the AP patient before treatment; 2: the same patient after successful therapy; 3: the same AP patient after clinically cured; 4: negative control. The amplified fragment length of β-actin is 520 bp, of TREM-1 is 232 bp. 10 g/L agarose gel.
Figure 4
The A ratios of TREM-1/β-actin in different stage of AP: 1, the group in the stage of before treatment. 2, the group in the stage after successful therapy. 3, the group in the stage of clinically cured. 4, the group of normal subject. There was a significant difference among the three stages in the expression of TREM-1 mRNA (groups 1, 2 and 3. P < 0.05). And in the group of clinically cured the ratio was higher than in healthy control subjects (P < 0.05).
Similar articles
- High Expression Levels of Trigger Receptor Expressed on Myeloid Cells-1 on Neutrophils Associated with Increased Severity of Acute Pancreatitis in Mice.
Liu M, Wu W, Zhao Q, Feng Q, Wang W. Liu M, et al. Biol Pharm Bull. 2015;38(10):1450-7. doi: 10.1248/bpb.b15-00057. Epub 2015 Aug 5. Biol Pharm Bull. 2015. PMID: 26250893 - Evaluation of the lipopolysaccharide-induced transcription of the human TREM-1 gene in vitamin D3-matured THP-1 macrophage-like cells.
Hosoda H, Tamura H, Nagaoka I. Hosoda H, et al. Int J Mol Med. 2015 Nov;36(5):1300-10. doi: 10.3892/ijmm.2015.2349. Epub 2015 Sep 18. Int J Mol Med. 2015. PMID: 26397033 - Triggering receptor expressed on myeloid cells-1 expression on monocytes is associated with inflammation but not with infection in acute pancreatitis.
Ferat-Osorio E, Wong-Baeza I, Esquivel-Callejas N, Figueroa-Figueroa S, Duarte-Rojo A, Guzmán-Valdivia-Gómez G, Rodea-Rosas H, Torres-González R, Sánchez-Fernández P, Arriaga-Pizano L, López-Macías C, Robles-Díaz G, Isibasi A. Ferat-Osorio E, et al. Crit Care. 2009;13(3):R69. doi: 10.1186/cc7876. Epub 2009 May 14. Crit Care. 2009. PMID: 19442309 Free PMC article. - Triggering receptor expressed on myeloid cells in the pathogenesis of periodontitis: potential novel treatment strategies.
Rudick CP, Miyamoto T, Lang MS, Agrawal DK. Rudick CP, et al. Expert Rev Clin Immunol. 2017 Dec;13(12):1189-1197. doi: 10.1080/1744666X.2017.1392855. Epub 2017 Oct 20. Expert Rev Clin Immunol. 2017. PMID: 29027827 Free PMC article. Review. - From expression to signaling: roles of TREM-1 and TREM-2 in innate immunity and bacterial infection.
Sharif O, Knapp S. Sharif O, et al. Immunobiology. 2008;213(9-10):701-13. doi: 10.1016/j.imbio.2008.07.008. Epub 2008 Sep 7. Immunobiology. 2008. PMID: 18926286 Review.
Cited by
- TNF-alpha promotes LPA1- and LPA3-mediated recruitment of leukocytes in vivo through CXCR2 ligand chemokines.
Zhao C, Sardella A, Chun J, Poubelle PE, Fernandes MJ, Bourgoin SG. Zhao C, et al. J Lipid Res. 2011 Jul;52(7):1307-18. doi: 10.1194/jlr.M008045. Epub 2011 Apr 26. J Lipid Res. 2011. PMID: 21521824 Free PMC article. - Relationship between expression of triggering receptor-1 on myeloid cells in intestinal tissue and intestinal barrier dysfunction in severe acute pancreatitis.
Yin K, Dang SC, Zhang JX. Yin K, et al. World J Emerg Med. 2011;2(3):216-21. doi: 10.5847/wjem.j.1920-8642.2011.03.011. World J Emerg Med. 2011. PMID: 25215013 Free PMC article. - Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma.
Manfredi GF, Celsa C, John C, Jones C, Acuti N, Scheiner B, Fulgenzi CAM, Korolewicz J, Pinter M, Gennari A, Mauri FA, Pirisi M, Minisini R, Vincenzi F, Burlone M, Rigamonti C, Donadon M, Cabibbo G, D'Alessio A, Pinato DJ. Manfredi GF, et al. J Hepatocell Carcinoma. 2023 Nov 3;10:1955-1971. doi: 10.2147/JHC.S291553. eCollection 2023. J Hepatocell Carcinoma. 2023. PMID: 37941812 Free PMC article. Review. - Intrapulmonary, adenovirus-mediated overexpression of KARAP/DAP12 enhances fungal clearance during invasive aspergillosis.
Carpenter KJ, Buckland KF, Xing Z, Hogaboam CM. Carpenter KJ, et al. Infect Immun. 2005 Dec;73(12):8402-6. doi: 10.1128/IAI.73.12.8402-8406.2005. Infect Immun. 2005. PMID: 16299339 Free PMC article. - Tumor necrosis factor-α regulates triggering receptor expressed on myeloid cells-1-dependent matrix metalloproteinases in the carotid plaques of symptomatic patients with carotid stenosis.
Rao VH, Rai V, Stoupa S, Subramanian S, Agrawal DK. Rao VH, et al. Atherosclerosis. 2016 May;248:160-9. doi: 10.1016/j.atherosclerosis.2016.03.021. Epub 2016 Mar 19. Atherosclerosis. 2016. PMID: 27017522 Free PMC article.
References
- Bouchon A, Dietrich J, Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol. 2000;164:4991–4995. - PubMed
- Bouchon A, Facchetti F, Weigand MA, Colonna M. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature. 2001;410:1103–1107. - PubMed
- The Pancrea Study Group, Chinese medical association of sugery. The standards on diagnosis and classification of acute pancreatitis (1996) Zhonghua Waike Zazhi. 1997;35:773–775.
- Abu-Zidan FM, Bonham MJ, Windsor JA. Severity of acute pancreatitis: a multivariate analysis of oxidative stress markers and modified Glasgow criteria. Br J Surg. 2000;87:1019–1023. - PubMed
- Bradley EL. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg. 1993;128:586–590. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous